Systems analysis of the human pulmonary arterial hypertension lung transcriptome

Robert Stearman, Quan M. Bui, Gil Speyer, Adam Handen, Amber R. Cornelius, Brian B. Graham, Seungchan Kim, Elizabeth A. Mickler, Rubin M. Tuder, Stephen Y. Chan, Mark W. Geraci

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Pulmonary arterial hypertension (PAH) is characterized by increased pulmonary artery pressure and vascular resistance, typically leading to right heart failure and death. Current therapies improve quality of life of the patients but have a modest effect on long-term survival. Adetailed transcriptomics and systems biology view of thePAHlung is expected to provide new testable hypotheses for exploring novel treatments. We completed transcriptomics analysis of PAH and control lung tissue to develop disease-specific and clinical data/tissue pathology gene expression classifiers from expression datasets. Gene expression data were integrated into pathway analyses. Gene expression microarray data were collected from 58 PAH and 25 control lung tissues. The strength of the dataset and its derived disease classifier was validated using multiple approaches. Pathways and upstream regulators analyses was completed with standard and novel graphical approaches. The PAH lung dataset identified expression patterns specific to PAH subtypes, clinical parameters, and lung pathology variables. Pathway analyses indicate the important global role of TNF and transforming growth factor signaling pathways. In addition, novel upstream regulators and insight into the cellular and innate immune responses driving PAH were identified. Finally, WNT-signaling pathways may be a major determinant underlying the observed sex differences in PAH. This study provides a transcriptional framework for the PAH-diseased lung, supported by previously reported findings, and will be a valuable resource to the PAHresearch community. Our investigation revealed novel potential targets and pathways amenable to further study in a variety of experimental systems.

Original languageEnglish (US)
Pages (from-to)637-649
Number of pages13
JournalAmerican Journal of Respiratory Cell and Molecular Biology
Volume60
Issue number6
DOIs
StatePublished - Jun 1 2019
Externally publishedYes

Fingerprint

Systems Analysis
Transcriptome
Pulmonary Hypertension
Gene expression
Systems analysis
Pathology
Tissue
Lung
Classifiers
Transforming Growth Factors
Microarrays
Gene Expression
Systems Biology
Innate Immunity
Cellular Immunity
Sex Characteristics
Vascular Resistance
Pulmonary Artery
Lung Diseases
Heart Failure

Keywords

  • Bioinformatics
  • Lung transcriptomics
  • Pulmonary arterial hypertension

ASJC Scopus subject areas

  • Molecular Biology
  • Pulmonary and Respiratory Medicine
  • Clinical Biochemistry
  • Cell Biology

Cite this

Systems analysis of the human pulmonary arterial hypertension lung transcriptome. / Stearman, Robert; Bui, Quan M.; Speyer, Gil; Handen, Adam; Cornelius, Amber R.; Graham, Brian B.; Kim, Seungchan; Mickler, Elizabeth A.; Tuder, Rubin M.; Chan, Stephen Y.; Geraci, Mark W.

In: American Journal of Respiratory Cell and Molecular Biology, Vol. 60, No. 6, 01.06.2019, p. 637-649.

Research output: Contribution to journalArticle

Stearman, R, Bui, QM, Speyer, G, Handen, A, Cornelius, AR, Graham, BB, Kim, S, Mickler, EA, Tuder, RM, Chan, SY & Geraci, MW 2019, 'Systems analysis of the human pulmonary arterial hypertension lung transcriptome', American Journal of Respiratory Cell and Molecular Biology, vol. 60, no. 6, pp. 637-649. https://doi.org/10.1165/rcmb.2018-0368OC
Stearman, Robert ; Bui, Quan M. ; Speyer, Gil ; Handen, Adam ; Cornelius, Amber R. ; Graham, Brian B. ; Kim, Seungchan ; Mickler, Elizabeth A. ; Tuder, Rubin M. ; Chan, Stephen Y. ; Geraci, Mark W. / Systems analysis of the human pulmonary arterial hypertension lung transcriptome. In: American Journal of Respiratory Cell and Molecular Biology. 2019 ; Vol. 60, No. 6. pp. 637-649.
@article{cbe620ed782243e4bfc66109a12fd014,
title = "Systems analysis of the human pulmonary arterial hypertension lung transcriptome",
abstract = "Pulmonary arterial hypertension (PAH) is characterized by increased pulmonary artery pressure and vascular resistance, typically leading to right heart failure and death. Current therapies improve quality of life of the patients but have a modest effect on long-term survival. Adetailed transcriptomics and systems biology view of thePAHlung is expected to provide new testable hypotheses for exploring novel treatments. We completed transcriptomics analysis of PAH and control lung tissue to develop disease-specific and clinical data/tissue pathology gene expression classifiers from expression datasets. Gene expression data were integrated into pathway analyses. Gene expression microarray data were collected from 58 PAH and 25 control lung tissues. The strength of the dataset and its derived disease classifier was validated using multiple approaches. Pathways and upstream regulators analyses was completed with standard and novel graphical approaches. The PAH lung dataset identified expression patterns specific to PAH subtypes, clinical parameters, and lung pathology variables. Pathway analyses indicate the important global role of TNF and transforming growth factor signaling pathways. In addition, novel upstream regulators and insight into the cellular and innate immune responses driving PAH were identified. Finally, WNT-signaling pathways may be a major determinant underlying the observed sex differences in PAH. This study provides a transcriptional framework for the PAH-diseased lung, supported by previously reported findings, and will be a valuable resource to the PAHresearch community. Our investigation revealed novel potential targets and pathways amenable to further study in a variety of experimental systems.",
keywords = "Bioinformatics, Lung transcriptomics, Pulmonary arterial hypertension",
author = "Robert Stearman and Bui, {Quan M.} and Gil Speyer and Adam Handen and Cornelius, {Amber R.} and Graham, {Brian B.} and Seungchan Kim and Mickler, {Elizabeth A.} and Tuder, {Rubin M.} and Chan, {Stephen Y.} and Geraci, {Mark W.}",
year = "2019",
month = "6",
day = "1",
doi = "10.1165/rcmb.2018-0368OC",
language = "English (US)",
volume = "60",
pages = "637--649",
journal = "American Journal of Respiratory Cell and Molecular Biology",
issn = "1044-1549",
publisher = "American Thoracic Society",
number = "6",

}

TY - JOUR

T1 - Systems analysis of the human pulmonary arterial hypertension lung transcriptome

AU - Stearman, Robert

AU - Bui, Quan M.

AU - Speyer, Gil

AU - Handen, Adam

AU - Cornelius, Amber R.

AU - Graham, Brian B.

AU - Kim, Seungchan

AU - Mickler, Elizabeth A.

AU - Tuder, Rubin M.

AU - Chan, Stephen Y.

AU - Geraci, Mark W.

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Pulmonary arterial hypertension (PAH) is characterized by increased pulmonary artery pressure and vascular resistance, typically leading to right heart failure and death. Current therapies improve quality of life of the patients but have a modest effect on long-term survival. Adetailed transcriptomics and systems biology view of thePAHlung is expected to provide new testable hypotheses for exploring novel treatments. We completed transcriptomics analysis of PAH and control lung tissue to develop disease-specific and clinical data/tissue pathology gene expression classifiers from expression datasets. Gene expression data were integrated into pathway analyses. Gene expression microarray data were collected from 58 PAH and 25 control lung tissues. The strength of the dataset and its derived disease classifier was validated using multiple approaches. Pathways and upstream regulators analyses was completed with standard and novel graphical approaches. The PAH lung dataset identified expression patterns specific to PAH subtypes, clinical parameters, and lung pathology variables. Pathway analyses indicate the important global role of TNF and transforming growth factor signaling pathways. In addition, novel upstream regulators and insight into the cellular and innate immune responses driving PAH were identified. Finally, WNT-signaling pathways may be a major determinant underlying the observed sex differences in PAH. This study provides a transcriptional framework for the PAH-diseased lung, supported by previously reported findings, and will be a valuable resource to the PAHresearch community. Our investigation revealed novel potential targets and pathways amenable to further study in a variety of experimental systems.

AB - Pulmonary arterial hypertension (PAH) is characterized by increased pulmonary artery pressure and vascular resistance, typically leading to right heart failure and death. Current therapies improve quality of life of the patients but have a modest effect on long-term survival. Adetailed transcriptomics and systems biology view of thePAHlung is expected to provide new testable hypotheses for exploring novel treatments. We completed transcriptomics analysis of PAH and control lung tissue to develop disease-specific and clinical data/tissue pathology gene expression classifiers from expression datasets. Gene expression data were integrated into pathway analyses. Gene expression microarray data were collected from 58 PAH and 25 control lung tissues. The strength of the dataset and its derived disease classifier was validated using multiple approaches. Pathways and upstream regulators analyses was completed with standard and novel graphical approaches. The PAH lung dataset identified expression patterns specific to PAH subtypes, clinical parameters, and lung pathology variables. Pathway analyses indicate the important global role of TNF and transforming growth factor signaling pathways. In addition, novel upstream regulators and insight into the cellular and innate immune responses driving PAH were identified. Finally, WNT-signaling pathways may be a major determinant underlying the observed sex differences in PAH. This study provides a transcriptional framework for the PAH-diseased lung, supported by previously reported findings, and will be a valuable resource to the PAHresearch community. Our investigation revealed novel potential targets and pathways amenable to further study in a variety of experimental systems.

KW - Bioinformatics

KW - Lung transcriptomics

KW - Pulmonary arterial hypertension

UR - http://www.scopus.com/inward/record.url?scp=85066766322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066766322&partnerID=8YFLogxK

U2 - 10.1165/rcmb.2018-0368OC

DO - 10.1165/rcmb.2018-0368OC

M3 - Article

C2 - 30562042

AN - SCOPUS:85066766322

VL - 60

SP - 637

EP - 649

JO - American Journal of Respiratory Cell and Molecular Biology

JF - American Journal of Respiratory Cell and Molecular Biology

SN - 1044-1549

IS - 6

ER -